Gene Therapy: Understanding Evolving Coverage and Reimbursement Challenges

Sponsored by: Manatt Health
Speakers:

Melinda Dutton, Partner, Manatt Health
Jon Glaudemans, Managing Director, Manatt Health
Sandy Robinson, Managing Director, Manatt Health

Wednesday - November 16, 2016 / 1:00pm ET
Free Event

Exciting advances in science have led to developing treatment breakthroughs—such as gene scripting therapies—that could represent the first potential cures for rare diseases and other life-threatening conditions.  Gene therapies offer dramatic promise—but also come with high costs.  When viewing gene therapies and other expensive treatment options against the backdrop of an evolving healthcare landscape, several reimbursement challenges emerge.

In a new webinar, Manatt Health examines the key issues that life sciences companies should consider when developing their reimbursement strategies for high-cost therapies, as both public and private payers struggle with balancing budgets against increasing demands.

The program will:

  • Explore the evolving landscape of expensive yet potentially curative therapies.
  • Analyze the challenges of care delivery and coordination to ensure patient access.
  • Discuss coverage and reimbursement challenges for both public and private payers.
  • Reveal innovative models that could potentially overcome coverage and reimbursement hurdles.

Even if you can’t make the November 16 session, register now and receive a link to view this “can’t miss” program on demand.

About the Sponsors

Health is everyone's business. Manatt works with clients who are passionate about improving healthcare for the benefit of all Americans.

For more information please visit www.manatt.com/manatt-health.

Comments are closed.

FEEDBACK